MIRZYME THERAPEUTICS

mirzyme-therapeutics-logo

MirZyme Therapeutics is an innovative biopharmaceutical company focused on the development and commercialisation of tailored therapeutics to prevent preeclampsia and fetal growth restriction in pregnancy. MirZyme provides a stratified approach to identify patients who will develop preeclampsia and has developed first in class drugs to prevent preeclampsia and fetal growth restrictions. We have two therapeutic approaches, small molecules in capsules form and injectable synthetic miRNAs. MirZyme. One Test. One Pill. Save Two Lives.

#People #Website #More

MIRZYME THERAPEUTICS

Industry:
Biopharma Biotechnology Health Care Medical Pharmaceutical

Founded:
2016-04-19

Address:
Birmingham, Birmingham, United Kingdom

Country:
United Kingdom

Website Url:
http://www.mirzyme.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
2.1 M USD


Founder


asif-ahmed_image

Asif Ahmed

Official Site Inspections

http://www.mirzyme.com

  • Host name: unalocated.63.wixsite.com
  • IP address: 185.230.63.186
  • Location: Ashburn United States
  • Latitude: 39.018
  • Longitude: -77.539
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20147

Loading ...

More informations about "Mirzyme Therapeutics"

Home | MirZyme Therapeutics

MirZyme Therapeutics offers the end-to-end preeclampsia solution. It is an early-stage clinical women's health biopharmaceutical company that has uncovered what causes preeclampsia โ€ฆSee details»

The Team - MirZyme Therapeutics

Founded in Birmingham in 2016 and located at Innovation Birmingham Campus, MirZyme Therapeutics is on a global mission to make preeclampsia history. Our value proposition is to save lives, reduce healthcare costs and promote โ€ฆSee details»

Preeclampsia | Asif Ahmed

Discoverer of two protective pathways to stop preeclampsia during pregnancy. Founder of MirZyme Therapeutics with globally granted patents to prevent preeclampsia. Founder of the most socially inclusive medical school in the โ€ฆSee details»

More about us - MirZyme Therapeutics

Our Pipeline. Our Science. Breakthrough discoveries; Preeclampsia; Fetal Growth RestrictionSee details»

Mirzyme Therapeutics - Crunchbase Company Profile & Funding

MirZyme Therapeutics is an innovative biopharmaceutical company focused on the development and commercialisation of tailored therapeutics to prevent preeclampsia and fetal growth โ€ฆSee details»

Health Medicine | Asif Ahmed

MirZyme has several global patents granted. These relate to a pipeline of product offerings that address the unmet medical needs of patients with preeclampsia. Uniquely, MirZyme will be the โ€ฆSee details»

MirZyme Therapeutics - LinkedIn

MirZyme Therapeutics is an innovative biopharmaceutical company that focuses on the development and commercialisation of diagnostics and drugs for women with pregnancy complications,...See details»

Mirzyme Therapeutics - Contacts, Employees, Board Members

MirZyme is an innovative company focused on the development of tailored therapeutics to prevent preeclampsia and fetal growth restriction.See details»

Concept Foundation and MirZyme Therapeutics to โ€ฆ

Apr 11, 2023ย ยท Concept Foundation and MirZyme Therapeutics, an innovative female health biotech, have partnered to close the gap in the availability of diagnostics and therapeutics for treatment of pre-eclampsia. The partnership โ€ฆSee details»

Concept Foundation and MirZyme Therapeutics to partner to help โ€ฆ

MirZyme Therapeutics (www.mirzyme.com) is the end-to-end pre-eclampsia solution. It is an early-stage clinical female health biopharmaceutical company that has solutions to predict and โ€ฆSee details»

Investors - MirZyme Therapeutics

If you or your organisation may be interested in investing in MirZyme then please contact us @ [email protected] for an NDA and access to our data room.See details»

MirZyme Company Profile 2024: Valuation, Funding & Investors

Operator of a femtech and deep tech life science biopharmaceutical platform intended to predict and prevent preeclampsia and promote longevity.See details»

MirZyme Therapeutics - Overview, News & Similar companies

View MirZyme Therapeutics (www.mirzyme.com) location in West Midlands, United Kingdom , revenue, industry and description. Find related and similar companies as well as employees โ€ฆSee details»

MIRZYME THERAPEUTICS LIMITED - Companies House

MIRZYME THERAPEUTICS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, โ€ฆSee details»

Our Pipeline | MirZyme Therapeutics

MirZyme has several patented pipelines of product offerings that address the unmet medical needs of patients with preeclampsia and/or Fetal Growth Restriction. Uniquely, MirZyme will โ€ฆSee details»

Thereโ€™s a femtech revolution and the UK is leading it

Jun 17, 2022ย ยท Mace sat down with Professor Asif Ahmed, Executive Chairman and Founder of MirZyme, a UK-based biopharmaceutical biotech company that focuses on the development โ€ฆSee details»

Mirzyme Therapeutics - Funding, Financials, Valuation & Investors

MirZyme is an innovative company focused on the development of tailored therapeutics to prevent preeclampsia and fetal growth restriction.See details»

News & Media | MirZyme Therapeutics

Dec 13, 2023ย ยท mirzyme therapeutics awarded the first fast-track innovation passport for the treatment of preeclampsia from the mhra, the uk regulator... May 14, 2023 CEO Nominated for โ€ฆSee details»

MirZyme Therapeutics | Birmingham - Facebook

UK Ltd biotech company working to improve maternal health and save lives by its pursuit of pioneering science to transform medicine.See details»

Our Blog - MirZyme Therapeutics

Sep 16, 2024ย ยท Mirzyme has been selected as a finalist for the Women's Health Innovation Showcase USA. Out of 125 companies, Mirzyme is one of 24 to be...See details»